Precision Biologics is a biotechnology company based in Bethesda, MD, dedicated to improving the lives of cancer patients through innovative therapeutic and diagnostic products. Their unique discovery platform allows them to develop patient tumor derived anticancer vaccines, targeted antibodies, and monoclonal antibodies that specifically target tumors without harming healthy cells.
With a focus on biotherapeutics, Precision Biologics utilizes breakthroughs in biotechnology to produce targeted antibodies that were not possible just a few years ago. They have a strong clinical pipeline, conducting clinical trials and publishing scientific articles in leading journals. Their commitment to advancing cancer treatment is evident through their participation in conferences and events, where they present new data and share their groundbreaking research.
Generated from the website